Amgen Company News

Oak Harvest Investment Services Reduces Stake in Amgen Inc. $AMGN - MarketBeat

Oak Harvest Investment Services Reduces Stake in Amgen Inc. $AMGN MarketBeat

Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen

Amgen CEO Bob Bradway's 2025 Letter to Shareholders Amgen

Amgen (AMGN) Laps the Stock Market: Here's Why - Yahoo Finance Singapore

Amgen (AMGN) Laps the Stock Market: Here's Why Yahoo Finance Singapore

Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com

Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents IPWatchdog.com

Amgen pipeline’s next growth cycle: replacing its old blockbusters - labiotech.eu

Amgen pipeline’s next growth cycle: replacing its old blockbusters labiotech.eu

UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 - Insider Monkey

UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 Insider Monkey

Assessing Whether Amgen (AMGN) Still Looks Undervalued After Recent Share Price Pullback - simplywall.st

Assessing Whether Amgen (AMGN) Still Looks Undervalued After Recent Share Price Pullback simplywall.st

Asset Management One Co. Ltd. Has $114.31 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

Asset Management One Co. Ltd. Has $114.31 Million Stock Position in Amgen Inc. $AMGN MarketBeat

Boehringer, Amgen discard early immunology candidates over lack of clinical potential - Fierce Biotech

Boehringer, Amgen discard early immunology candidates over lack of clinical potential Fierce Biotech

2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen

2025 at Amgen: Investing, Expanding, and Serving More Patients Amgen

Amgen Inc. $AMGN Shares Sold by Whittier Trust Co. - MarketBeat

Amgen Inc. $AMGN Shares Sold by Whittier Trust Co. MarketBeat

Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen

Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere Amgen

AE Wealth Management LLC Has $43.90 Million Holdings in Amgen Inc. $AMGN - MarketBeat

AE Wealth Management LLC Has $43.90 Million Holdings in Amgen Inc. $AMGN MarketBeat

Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen

Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report Amgen

Amgen Inc. $AMGN Shares Purchased by Farther Finance Advisors LLC - MarketBeat

Amgen Inc. $AMGN Shares Purchased by Farther Finance Advisors LLC MarketBeat

Amgen Inc. $AMGN Shares Acquired by Lbp Am Sa - MarketBeat

Amgen Inc. $AMGN Shares Acquired by Lbp Am Sa MarketBeat

Amgen Inc. $AMGN Shares Bought by Cwm LLC - MarketBeat

Amgen Inc. $AMGN Shares Bought by Cwm LLC MarketBeat

Mirae Asset Global Investments Co. Ltd. Has $186.70 Million Stake in Amgen Inc. $AMGN - MarketBeat

Mirae Asset Global Investments Co. Ltd. Has $186.70 Million Stake in Amgen Inc. $AMGN MarketBeat

KBC Group NV Has $187.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

KBC Group NV Has $187.27 Million Stock Holdings in Amgen Inc. $AMGN MarketBeat

Argo Wealth Advisory LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat

Argo Wealth Advisory LLC Purchases New Shares in Amgen Inc. $AMGN MarketBeat

Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside? - AD HOC NEWS

Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside? AD HOC NEWS

Amgen Once Again Recognized as Top Pharma Company by U.S. Patients - Amgen

Amgen Once Again Recognized as Top Pharma Company by U.S. Patients Amgen

2 Reasons to Like AMGN and 1 to Stay Skeptical - StockStory

2 Reasons to Like AMGN and 1 to Stay Skeptical StockStory

Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen

Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. Amgen

Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen

Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow Amgen

Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen

Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 Amgen